Nu-Med Plus (NUMD) Shares Outstanding (Weighted Average) (2011 - 2025)

Nu-Med Plus' Shares Outstanding (Weighted Average) history runs 15 years deep, the most recent figure standing at $83.5 million for Q4 2025.

• In Q4 2025, Shares Outstanding (Weighted Average) changed 0.0% year-over-year to $83.5 million; the TTM figure through Dec 2025 stood at $83.5 million (changed 0.0% YoY), while the FY2025 annual figure was $83.5 million, changed 0.0% from the prior year.
• Shares Outstanding (Weighted Average) came in at $83.5 million for Q4 2025 at Nu-Med Plus, roughly flat from $83.5 million in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $83.5 million in Q1 2024 to a low of $73.4 million in Q4 2021.
• A 5-year average of $81.2 million and a median of $81.3 million in 2023 frame the typical range for Shares Outstanding (Weighted Average).
• Across the five-year window, Shares Outstanding (Weighted Average) surged 70.29% in 2021 and changed 0.0% in 2025, its largest moves.
• Nu-Med Plus' Shares Outstanding (Weighted Average) stood at $73.4 million in 2021, then climbed by 8.96% to $80.0 million in 2022, then increased by 2.15% to $81.7 million in 2023, then gained by 2.3% to $83.5 million in 2024, then changed by 0.0% to $83.5 million in 2025.
• According to Business Quant data, Shares Outstanding (Weighted Average) over the past three periods registered $83.5 million, $83.5 million, and $83.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.

Peer Comparison